MARKER THERAPEUTICS, INC. Option Indexed to Issuer's Equity, Shares
MARKER THERAPEUTICS, INC. (MRKR) reported Option Indexed to Issuer's Equity, Shares of 439.00 thousand shares for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Notes › Other Liabilities › Derivative Financial Instruments Indexed to, and Potentially Settled in, Entity's Own Stock
us-gaap:OptionIndexedToIssuersEquityShares · last filed 2018-08-09
- MARKER THERAPEUTICS, INC. option indexed to issuer's equity, shares for the quarter ending 2018-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- MARKER THERAPEUTICS, INC. option indexed to issuer's equity, shares for the quarter ending 2018-03-31 was 439.00K shares, a 5.28% increase year-over-year.
- MARKER THERAPEUTICS, INC. option indexed to issuer's equity, shares for the quarter ending 2017-12-31 was 34.00K shares.
- MARKER THERAPEUTICS, INC. option indexed to issuer's equity, shares for the quarter ending 2017-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- MARKER THERAPEUTICS, INC. option indexed to issuer's equity, shares for fiscal 2017 was 489.00K shares, a 13.19% increase from fiscal 2016.
- MARKER THERAPEUTICS, INC. option indexed to issuer's equity, shares for fiscal 2016 was 432.00K shares, a 44.48% increase from fiscal 2015.
- MARKER THERAPEUTICS, INC. option indexed to issuer's equity, shares for fiscal 2015 was 299.00K shares, a 356.98% increase from fiscal 2014.
- MARKER THERAPEUTICS, INC. option indexed to issuer's equity, shares for fiscal 2014 was 65.43K shares.
| Period end | Option Indexed to Issuer's Equity, Shares 3 month | Option Indexed to Issuer's Equity, Shares 3 month as first filed | Option Indexed to Issuer's Equity, Shares 6 month | Option Indexed to Issuer's Equity, Shares 6 month as first filed | Option Indexed to Issuer's Equity, Shares 9 month | Option Indexed to Issuer's Equity, Shares 9 month as first filed | Option Indexed to Issuer's Equity, Shares 12 month | Option Indexed to Issuer's Equity, Shares 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 439.00K shares 10-Q · filed 2018-08-09 | 473.00K shares derived: sum of 3 quarters · filed 2018-08-09 | 473.00K shares derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2018-03-31 | 439.00K shares 10-Q · filed 2018-05-15 | 473.00K shares derived: sum of 2 quarters · filed 2018-05-15 | 473.00K shares derived: sum of 3 quarters · filed 2018-05-15 | 928.00K shares derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2017-12-31 | 34.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | 34.00K shares derived: sum of 2 quarters · filed 2018-03-23 | 489.00K shares derived: sum of 3 quarters · filed 2018-03-23 | 489.00K shares 10-K · filed 2018-03-23 | ||||
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | 455.00K shares derived: sum of 2 quarters · filed 2017-11-14 | 455.00K shares 10-Q · filed 2017-11-14 | 872.00K shares derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2017-06-30 | 455.00K shares 10-Q · filed 2017-08-07 | 455.00K shares 10-Q · filed 2018-08-09 | 872.00K shares derived: sum of 3 quarters · filed 2018-05-15 | 1.01M shares derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2017-03-31 | 417.00K shares 10-Q · filed 2018-05-15 | 417.00K shares derived: sum of 2 quarters · filed 2018-05-15 | 552.00K shares derived: sum of 3 quarters · filed 2018-05-15 | 803.00K shares derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | 135.00K shares derived: sum of 2 quarters · filed 2018-03-23 | 386.00K shares derived: sum of 3 quarters · filed 2018-03-23 | 432.00K shares 10-K · filed 2018-03-23 | 434.00K shares 10-K · filed 2017-03-14 | |||
| 2016-09-30 | 135.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | 386.00K shares derived: sum of 2 quarters · filed 2017-11-14 | 432.00K shares 10-Q · filed 2017-11-14 | 945.00K shares derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | 251.00K shares 10-Q · filed 2017-08-07 | 3.01M shares 10-Q · filed 2016-08-15 | 297.00K shares 10-Q · filed 2017-08-07 | 3.56M shares 10-Q · filed 2016-08-15 | 810.00K shares derived: sum of 3 quarters · filed 2017-08-07 | 384.00K shares derived: sum of 4 quarters · filed 2017-08-07 | ||
| 2016-03-31 | 299.00K shares 10-Q · filed 2017-05-05 | 3.58M shares 10-Q · filed 2016-05-16 | 559.00K shares derived: sum of 2 quarters · filed 2017-05-05 | 133.00K shares derived: sum of 3 quarters · filed 2017-05-05 | 598.00K shares derived: sum of 4 quarters · filed 2017-05-05 | |||
| 2015-12-31 | 260.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -166.00K shares derived: sum of 2 quarters · filed 2017-03-14 | 299.00K shares derived: sum of 3 quarters · filed 2017-03-14 | 299.00K shares 10-K · filed 2017-03-14 | 3.58M shares 10-K · filed 2016-04-14 | |||
| 2015-09-30 | -426.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | 39.00K shares derived: sum of 2 quarters · filed 2016-11-04 | 39.00K shares 10-Q · filed 2016-11-04 | 465.00K shares 10-Q · filed 2015-11-16 | 104.43K shares derived: sum of 4 quarters · filed 2016-11-04 | |||
| 2015-06-30 | 465.00K shares 10-Q · filed 2016-08-15 | 465.00K shares 10-Q · filed 2016-08-15 | 530.43K shares derived: sum of 3 quarters · filed 2016-08-15 | |||||
| 2015-03-31 | 65.00K shares 10-Q · filed 2016-05-16 | 65.43K shares derived: sum of 2 quarters · filed 2016-05-16 | ||||||
| 2014-12-31 | 430.00 shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2016-04-14 | 65.43K shares 10-K · filed 2016-04-14 | ||||||
| 2014-09-30 | 65.00K shares 10-Q/A · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |